Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06112314
Title IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) (PRISM-MEL-301)
Acronym PRISM-MEL-301
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Immunocore Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Prisma Health Cancer Institute RECRUITING Greenville South Carolina 29605 United States Details
University of Sydney - Melanoma Institute Australia (MIA) - The Poche Centre RECRUITING Wollstonecraft Australia Details
The University of Queensland (UQ) - Princess Alexandra Hospital (PAH) RECRUITING Woolloongabba Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field